Facebook
Twitter
LinkedIn
Forward
Primary Care Symposium 2023
This symposium serves to provide an annual update of best practices related to current topics in primary care. The goal of this symposium is for each participating provider to increase awareness of evidence-based guidelines pertaining to evaluation, treatment and management of topics discussed and utilize the recommendations provided. This year’s focus is on oncology and genetic testing, blood cancers, cardiac calcium scores, nephrology, chiari malformation, and medical marijuana use.
Target Audience
Family physicians, general internists, psychologists, hospitalists, physician assistants, nurse practitioners, nurses, pharmacists, dieticians and respiratory therapists.
Learning Objectives
As a result of attending this activity, the participant will be able to:
Evaluate patients of all ages using the most current medical trends.
Demonstrate increased knowledge on the most recent pharmacological agents available.
Assess the most appropriate treatment for patients in the primary care setting.
Time | Title |
|---|---|
| 7:30am–7:50am | Registration/Breakfast |
| 7:50am–8:00am | Welcome & Opening Remarks |
| 8:00am–8:50am | Chiari Malformation – Dr. Colin Buchanan |
| 8:50am–9:40am | Oncology, Family History/Genetic Testing – Dr. Sami Diab |
| 9:40am–10:30am | MGUS and Blood Cancers – Dr. John Burke |
| 10:30am–11:20am | Cardiac CT Calcium Scores – Dr. Ryan Maybrook |
| 11:20am–11:50am | Break for lunch |
| 11:50am–12:40pm | Nephrology, CKD Work Ups, New Meds – Dr. Andrew Brookens |
| 12:40am–1:30pm | Marijuana Education – Dr. Chris Rogers |
| 1:30pm–1:40pm | Closing remarks & Adjourn |
Accreditation:
The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
The HCA Healthcare Continental Division designates this live activity for a maximum of 5.0 AMA PRA Category 1TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support:
This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.
Disclosure:
The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.
Available Credit
- 5.00 AMA PRA Category 1 Credit™HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
HCA Healthcare Continental Division designates this for a maximum of 5.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 5.00 Attendance